Found 8 matching trials
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer PHASE1 The purpose of this study is to evaluate the safety and immune response of ...
Show More Location
Teikyo University
Learn More & Join Trial
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1 The purpose of this study is to evaluate the safety and time to progression...
Show More Location
The Institutute of Medical Science, University of Tokyo
Learn More & Join Trial
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer PHASE1 The purpose of this study is to evaluate the safety and time to progression...
Show More Location
The Institute of Medical Science, The University of Tokyo
Learn More & Join Trial
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer PHASE1 The purpose of this study is to evaluate the safety and time to progression...
Show More Location
The Institutute of Medical Science, University of Tokyo
Learn More & Join Trial
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1 The purpose of this study is to evaluate the safety and time to progression...
Show More Location
The Institutute of Medical Science, University of Tokyo
Learn More & Join Trial
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer PHASE1 The purpose of this study is to evaluate the safety, tolerability, immune r...
Show More Location
Fukushima Medical University
Learn More & Join Trial
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer PHASE1 The purpose of this study is to evaluate the safety, tolerability, immune r...
Show More Location
Fukushima Medical University Hospital
Learn More & Join Trial
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer PHASE1 This is a phase 1 study of multiple peptide vaccine therapy and GM-CSF in t...
Show More Location
Takuya Takayama M.D.Ph.D
Learn More & Join Trial